ITRM20040403A1 - Mutanti di shigella nelle funzioni relative ai processi di maturazione e riciclaggio dei peptidoglicani e loro usi come immunogeni. - Google Patents

Mutanti di shigella nelle funzioni relative ai processi di maturazione e riciclaggio dei peptidoglicani e loro usi come immunogeni.

Info

Publication number
ITRM20040403A1
ITRM20040403A1 IT000403A ITRM20040403A ITRM20040403A1 IT RM20040403 A1 ITRM20040403 A1 IT RM20040403A1 IT 000403 A IT000403 A IT 000403A IT RM20040403 A ITRM20040403 A IT RM20040403A IT RM20040403 A1 ITRM20040403 A1 IT RM20040403A1
Authority
IT
Italy
Prior art keywords
peptidoglicans
immunogenic
maturation
functions relating
recycling processes
Prior art date
Application number
IT000403A
Other languages
English (en)
Inventor
Maria Lina Bernardini
Philippe J Sansonetti
Original Assignee
Pasteur Institut
Univ Roma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Univ Roma filed Critical Pasteur Institut
Priority to IT000403A priority Critical patent/ITRM20040403A1/it
Publication of ITRM20040403A1 publication Critical patent/ITRM20040403A1/it
Priority to EP05769501A priority patent/EP1789532A1/en
Priority to CA002576124A priority patent/CA2576124A1/en
Priority to PCT/IT2005/000472 priority patent/WO2006013610A1/en
Priority to US11/659,461 priority patent/US20100291148A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IT000403A 2004-08-05 2004-08-05 Mutanti di shigella nelle funzioni relative ai processi di maturazione e riciclaggio dei peptidoglicani e loro usi come immunogeni. ITRM20040403A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT000403A ITRM20040403A1 (it) 2004-08-05 2004-08-05 Mutanti di shigella nelle funzioni relative ai processi di maturazione e riciclaggio dei peptidoglicani e loro usi come immunogeni.
EP05769501A EP1789532A1 (en) 2004-08-05 2005-08-04 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens
CA002576124A CA2576124A1 (en) 2004-08-05 2005-08-04 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens
PCT/IT2005/000472 WO2006013610A1 (en) 2004-08-05 2005-08-04 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens
US11/659,461 US20100291148A1 (en) 2004-08-05 2005-08-04 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000403A ITRM20040403A1 (it) 2004-08-05 2004-08-05 Mutanti di shigella nelle funzioni relative ai processi di maturazione e riciclaggio dei peptidoglicani e loro usi come immunogeni.

Publications (1)

Publication Number Publication Date
ITRM20040403A1 true ITRM20040403A1 (it) 2004-11-05

Family

ID=35295362

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000403A ITRM20040403A1 (it) 2004-08-05 2004-08-05 Mutanti di shigella nelle funzioni relative ai processi di maturazione e riciclaggio dei peptidoglicani e loro usi come immunogeni.

Country Status (5)

Country Link
US (1) US20100291148A1 (it)
EP (1) EP1789532A1 (it)
CA (1) CA2576124A1 (it)
IT (1) ITRM20040403A1 (it)
WO (1) WO2006013610A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2890859B1 (fr) 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase
KR101830784B1 (ko) 2011-09-09 2018-02-22 삼성전자주식회사 폴리머 및 상기 폴리머를 포함한 유기 발광 소자
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Also Published As

Publication number Publication date
WO2006013610A1 (en) 2006-02-09
EP1789532A1 (en) 2007-05-30
US20100291148A1 (en) 2010-11-18
CA2576124A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
NO345018B1 (no) Framgangsmåte for framstilling av organofluorforbindelser i alkoholholdige løsningsmidler.
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
GB2410919B (en) Improvements in or relating to the treatment of waste
NO20044175L (no) Anvendelse av epotiloner ved behandling av hjernesykdom relatert til proliferative prosesser
PL1933840T3 (pl) Zastosowanie delmopinolu w leczeniu trądziku
TH24528S1 (th) บันไดสำเร็จรูป
TH86373B (th) กระเป๋า
TH85564B (th) ขวด
TH89951S (th) มือจับ
TH134457S (th) หูหิ้ว
TH87744S (th) "ด้ามแปรงสีฟัน"
TH87743S (th) "ด้ามแปรงสีฟัน"
TH84528B (th) " กางเกงผ้าอ้อม "
TH105204S (th) "มือจับ"
TH82568B (th) "สวิตซ์"
TH87605S (th) พวงกุญแจ
TH79908S (th) โต๊ะ
TH23519S1 (th) โต๊ะ
TH23520S1 (th) โต๊ะ
TH86326B (th) กระเป๋า
TH89709B (th) กระเป๋า
TH87234B (th) กระเป๋า
TH87237B (th) กระเป๋า
TH87235B (th) กระเป๋า
TH29831S1 (th) ตัวดึงซิป